BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanaka M, Bohár Z, Vécsei L. Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism. Molecules 2020;25:E564. [PMID: 32012948 DOI: 10.3390/molecules25030564] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Gong X, Chang R, Zou J, Tan S, Huang Z. The role and mechanism of tryptophan - kynurenine metabolic pathway in depression. Rev Neurosci 2022. [PMID: 36054612 DOI: 10.1515/revneuro-2022-0047] [Reference Citation Analysis]
2 Tanaka M, Szabó Á, Spekker E, Polyák H, Tóth F, Vécsei L. Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System. Cells 2022;11:2607. [PMID: 36010683 DOI: 10.3390/cells11162607] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Shi J, Yin Q, Zhang L, Wu Y, Yi P, Guo M, Li H, Yuan L, Wang Z, Zhuang P, Zhang Y. Zi Shen Wan Fang Attenuates Neuroinflammation and Cognitive Function Via Remodeling the Gut Microbiota in Diabetes-Induced Cognitive Impairment Mice. Front Pharmacol 2022;13:898360. [DOI: 10.3389/fphar.2022.898360] [Reference Citation Analysis]
4 Jamshed L, Debnath A, Jamshed S, Wish JV, Raine JC, Tomy GT, Thomas PJ, Holloway AC. An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway. Int J Mol Sci 2022;23:6300. [PMID: 35682980 DOI: 10.3390/ijms23116300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shandilya S, Kumar S, Kumar Jha N, Kumar Kesari K, Ruokolainen J. Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection. Journal of Advanced Research 2022;38:223-44. [DOI: 10.1016/j.jare.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sellitto M, Terenzi D, Starita F, Di Pellegrino G, Battaglia S. The Cost of Imagined Actions in a Reward-Valuation Task. Brain Sciences 2022;12:582. [DOI: 10.3390/brainsci12050582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Martos D, Tuka B, Tanaka M, Vécsei L, Telegdy G. Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission. Biomedicines 2022;10:849. [DOI: 10.3390/biomedicines10040849] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
8 He S, Granot-Hershkovitz E, Zhang Y, Bressler J, Tarraf W, Yu B, Huang T, Zeng D, Wassertheil-Smoller S, Lamar M, Daviglus M, Marquine MJ, Cai J, Mosley T, Kaplan R, Boerwinkle E, Fornage M, DeCarli C, Kristal B, Gonzalez HM, Sofer T. Blood metabolites predicting mild cognitive impairment in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL). Alzheimers Dement (Amst) 2022;14:e12259. [PMID: 35229015 DOI: 10.1002/dad2.12259] [Reference Citation Analysis]
9 Bai MY, Lovejoy DB, Guillemin GJ, Kozak R, Stone TW, Koola MM. Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders. Complex Psychiatry 2021;7:19-33. [PMID: 35141700 DOI: 10.1159/000515066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ramírez Ortega D, Ugalde Muñiz PE, Blanco Ayala T, Vázquez Cervantes GI, Lugo Huitrón R, Pineda B, González Esquivel DF, Pérez de la Cruz G, Pedraza Chaverrí J, Sánchez Chapul L, Gómez-Manzo S, Pérez de la Cruz V. On the Antioxidant Properties of L-Kynurenine: An Efficient ROS Scavenger and Enhancer of Rat Brain Antioxidant Defense. Antioxidants (Basel) 2021;11:31. [PMID: 35052535 DOI: 10.3390/antiox11010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ciapała K, Mika J, Rojewska E. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives. Int J Mol Sci 2021;22:11055. [PMID: 34681715 DOI: 10.3390/ijms222011055] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
12 Chan HJ, Yanshree, Roy J, Tipoe GL, Fung ML, Lim LW. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease. Int J Mol Sci 2021;22:10151. [PMID: 34576314 DOI: 10.3390/ijms221810151] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
13 Poles MZ, Nászai A, Gulácsi L, Czakó BL, Gál KG, Glenz RJ, Dookhun D, Rutai A, Tallósy SP, Szabó A, Lőrinczi B, Szatmári I, Fülöp F, Vécsei L, Boros M, Juhász L, Kaszaki J. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats. Front Immunol 2021;12:717157. [PMID: 34475875 DOI: 10.3389/fimmu.2021.717157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G. Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review. Nutrients 2021;13:2966. [PMID: 34578844 DOI: 10.3390/nu13092966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tanaka M, Török N, Tóth F, Szabó Á, Vécsei L. Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines 2021;9:897. [PMID: 34440101 DOI: 10.3390/biomedicines9080897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D. Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders. Cells 2021;10:1603. [PMID: 34206739 DOI: 10.3390/cells10071603] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
17 Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines 2021;9:734. [PMID: 34202246 DOI: 10.3390/biomedicines9070734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 52] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sandi D, Fricska-Nagy Z, Bencsik K, Vécsei L. Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players. Molecules 2021;26:3423. [PMID: 34198750 DOI: 10.3390/molecules26113423] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Brown SJ, Huang XF, Newell KA. The kynurenine pathway in major depression: What we know and where to next. Neurosci Biobehav Rev 2021;127:917-27. [PMID: 34029552 DOI: 10.1016/j.neubiorev.2021.05.018] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
20 Balogh L, Tanaka M, Török N, Vécsei L, Taguchi S. Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders. Biomedicines 2021;9:340. [PMID: 33801765 DOI: 10.3390/biomedicines9040340] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
21 Adams JD. Probable Causes of Alzheimer’s Disease. Sci 2021;3:16. [DOI: 10.3390/sci3010016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Correia BSB, Nani JV, Waladares Ricardo R, Stanisic D, Costa TBBC, Hayashi MAF, Tasic L. Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia. Biomedicines 2021;9:235. [PMID: 33652776 DOI: 10.3390/biomedicines9030235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
23 Török N, Tanaka M, Vécsei L. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway. Int J Mol Sci 2020;21:E9338. [PMID: 33302404 DOI: 10.3390/ijms21249338] [Cited by in Crossref: 17] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
24 Verma V, Singh D, Kh R. Sinapic Acid Alleviates Oxidative Stress and Neuro-Inflammatory Changes in Sporadic Model of Alzheimer's Disease in Rats. Brain Sci 2020;10:E923. [PMID: 33266113 DOI: 10.3390/brainsci10120923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
25 Juhász L, Rutai A, Fejes R, Tallósy SP, Poles MZ, Szabó A, Szatmári I, Fülöp F, Vécsei L, Boros M, Kaszaki J. Divergent Effects of the N-Methyl-D-Aspartate Receptor Antagonist Kynurenic Acid and the Synthetic Analog SZR-72 on Microcirculatory and Mitochondrial Dysfunction in Experimental Sepsis. Front Med (Lausanne) 2020;7:566582. [PMID: 33330526 DOI: 10.3389/fmed.2020.566582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19? J Pers Med 2020;10:E217. [PMID: 33182350 DOI: 10.3390/jpm10040217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Małgorzata P, Paweł K, Iwona ML, Brzostek T, Andrzej P. Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets. Expert Opin Ther Targets 2020;24:1187-209. [PMID: 33138678 DOI: 10.1080/14728222.2020.1836160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
28 Diez-Iriepa D, Chamorro B, Talaván M, Chioua M, Iriepa I, Hadjipavlou-Litina D, López-Muñoz F, Marco-Contelles J, Oset-Gasque MJ. Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties. Int J Mol Sci 2020;21:E7949. [PMID: 33114714 DOI: 10.3390/ijms21217949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Tanaka M, Vécsei L. Monitoring the Redox Status in Multiple Sclerosis. Biomedicines 2020;8:E406. [PMID: 33053739 DOI: 10.3390/biomedicines8100406] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
30 Erabi H, Okada G, Shibasaki C, Setoyama D, Kang D, Takamura M, Yoshino A, Fuchikami M, Kurata A, Kato TA, Yamawaki S, Okamoto Y. Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis. Sci Rep 2020;10:16822. [PMID: 33033336 DOI: 10.1038/s41598-020-73918-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
31 Carrillo-mora P, Pérez-de la Cruz V, Estrada-cortés B, Toussaint-gonzález P, Martínez-cortéz JA, Rodríguez-barragán M, Quinzaños-fresnedo J, Rangel-caballero F, Gamboa-coria G, Sánchez-vázquez I, Barajas-martínez K, Franyutti-prado K, Sánchez-chapul L, Ramírez-ortega D, Ramos-chávez LA. Serum Kynurenines Correlate With Depressive Symptoms and Disability in Poststroke Patients: A Cross-sectional Study. Neurorehabil Neural Repair 2020;34:936-44. [DOI: 10.1177/1545968320953671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
32 Chen YY, Wang MC, Wang YN, Hu HH, Liu QQ, Liu HJ, Zhao YY. Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy. Biomark Res 2020;8:42. [PMID: 32944245 DOI: 10.1186/s40364-020-00218-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
33 Hunt C, Macedo E Cordeiro T, Suchting R, de Dios C, Cuellar Leal VA, Soares JC, Dantzer R, Teixeira AL, Selvaraj S. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis. Neurosci Biobehav Rev 2020;118:514-23. [PMID: 32853625 DOI: 10.1016/j.neubiorev.2020.08.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
34 Jovanovic F, Candido KD, Knezevic NN. The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents. Int J Mol Sci 2020;21:E6045. [PMID: 32842609 DOI: 10.3390/ijms21176045] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 17.5] [Reference Citation Analysis]
35 Koola MM. Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond. Psychiatry Res 2020;293:113409. [PMID: 32829072 DOI: 10.1016/j.psychres.2020.113409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
36 Biernacki T, Sandi D, Bencsik K, Vécsei L. Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives. Cells 2020;9:E1564. [PMID: 32604956 DOI: 10.3390/cells9061564] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
37 Tanaka M, Toldi J, Vécsei L. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines. Int J Mol Sci 2020;21:E2431. [PMID: 32244523 DOI: 10.3390/ijms21072431] [Cited by in Crossref: 32] [Cited by in F6Publishing: 80] [Article Influence: 16.0] [Reference Citation Analysis]